Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Brambilla; Gaetano
Address:
Parma, IT
No. of patents:
18
Patents:












Patent Number Title Of Patent Date Issued
8182791 Formulations for use in inhaler devices May 22, 2012
A formulation for an inhaler device comprises carrier particles having a diameter of at least 50 .mu.m and a mass median diameter of at least 175 .mu.m; active particles; and additive material to which is able to promote release of the active particles from the carrier particles on a
8142763 Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HF March 27, 2012
The invention relates to pressurized metered dose inhalers (MDIs) in which all or part of the internal surface is stainless steel, anodized aluminum, or lined with an inert organic coating and which contain a formulation which comprises ipratropium bromide.
8088362 Salmeterol superfine formulation January 3, 2012
The present invention relates to a pharmaceutical formulation for use in the administration of a long-acting .beta..sub.2-agonist by inhalation. In particular this invention relates to a chemically stable, highly efficient salmeterol HFA solution formulation to be administered by pre
7740463 Pressurised metered dose inhalers (MDI) June 22, 2010
The invention relates to the use of pressurised metered dose inhalers (MDIs) having part or all of their internal surfaces consisting of stainless steel, anodised aluminium or lined with an inert organic coating; and to compositions to be delivered with said MDIs.
7601336 Pharmaceutical aerosol composition October 13, 2009
A composition for use in an aerosol inhaler, the composition comprising an active material, a propellant containing a hydrofluoroalkane (HFA), a cosolvent and further comprising a low volatility component to increase the mass median aerodynamic diameter (MMAD) of the aerosol particles on
7541022 Pharmaceutical formulations for dry powder inhalers June 2, 2009
A powder for use in a dry powder inhaler comprises: i) a fraction n of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse particles; and iii) at least one active ingredient. The powder is suitable for efficacious
7347199 Pressurised metered dose inhalers (MDI) March 25, 2008
The invention relates to the use of pressurized metered dose inhalers (MDIs) having part or all of their internal surfaces consisting of stainless steel, anodised aluminum or lined with an inert organic coating; and to compositions to be delivered with said MDIs.
7223748 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets May 29, 2007
The invention provides a formulation to be administered as a dry powder for inhalation suitable for efficacious delivery of active ingredients into the low respiratory tract of patients suffering from a pulmonary disease such as asthma. In particular, the invention provides a formula
7223381 Pressurised metered dose inhalers (MDI) May 29, 2007
The invention relates to the use of pressurized metered dose inhalers (MDIs) having part or all of their internal surfaces consisting of stainless steel, anodized aluminum or lined with an inert organic coating; and to compositions to be delivered with said MDIs.
7018618 Stable pharmaceutical solution formulations for pressurized metered dose inhalers March 28, 2006
An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter (MMAD) of the aerosol particles on actuation of
6967017 Formulations of steroid solutions for inhalatory administration November 22, 2005
The present invention relates to optimized formulations of antiinflammatory steroids for nebulisation and a process for the preparation thereof. More particularly, the invention relates to formulations for monodose or multidose vials in the form of preservative-free stable solutions of a
6964759 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmona November 15, 2005
Formulations for the administration through pressurized metered dose aerosol inhalers containing an anticholineric drug in solution in a hydrofluorocarbon propellant, a cosolvent and a low volatility component, and the use thereof in chronic obstructive pulmonary disease.
6884794 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets April 26, 2005
The invention provides a formulation to be administered as dry powder for inhalation suitable for efficacious delivery of active ingredients into the low respiratory tract of patients suffering of pulmonary diseases such as asthma. In particular, the invention provides a formulation to b
6716414 Stable pharmaceutical solution formulations for pressurized metered dose inhalers April 6, 2004
An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter (MMAD) of the aerosol particles on actuation of
6713047 Pharmaceutical aerosol composition containing HFA 227 and HFA 134a March 30, 2004
In a solution composition for use in an aerosol inhaler which comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility compound the use of a mixture of HFA 134a and HFA 227 allows to modulate the mass median aerodynamic diamet
6667056 Pharmaceutical compositions containing an effervescent acid-base couple December 23, 2003
A pharmaceutical formulation in the form of a fast dissolving tablet comprising an active ingredient, sodium glycine carbonate and an acid capable of reacting rapidly with sodium glycine carbonate to release carbon dioxide.
6464958 Process for the preparation of suspensions of drug particles for inhalation delivery October 15, 2002
The invention is directed to a process for the preparation of suspensions of drug particles for inhalation delivery, said process providing particles of optimized particle size and distribution homogeneously dispersed in the carrier. The process, which is also suitable for the prepar
6284272 Pharmaceutical compositions containing an effervescent acid-base couple September 4, 2001
A pharmaceutical composition in the form of effervescent tablets comprising an active ingredient and an effervescent blend, wherein the effervescent blend comprises an acidic component and sodium glycine carbonate as alkaline components. Preferred acid components are fumaric acid, maleic










 
 
  Recently Added Patents
Electric connector
Systems for fastening a head stack to a hard drive base assembly
Stud for stud welding
Database virtualization
Mobile code decoding fault recovery via history data analysis
Clock and power fault detection for memory modules
Process for machining pressure detection hole and apparatus for machining pressure detection hole
  Randomly Featured Patents
Postexposure prevention of HIV infection or seroconversion
Tool for positioning molding
Method for creating patterns for producing integrated circuits
Backlight apparatus and liquid crystal display apparatus
Concealed slab fastener
Substituted azacyclic or azabicyclic compounds with affinity and selectivity for nicotinic cholinergic receptors
Sterile packing and sterilization method using this packing
Multi-strand electrical cable
Underground cable duct components and method of installing multiple cables therethrough
Cellular communication terminals and methods that sense terminal movement for cursor control